Prenexus Health Revenue and Competitors
Estimated Revenue & Valuation
- Prenexus Health's estimated annual revenue is currently $4.7M per year.
- Prenexus Health's estimated revenue per employee is $189,000
Employee Data
- Prenexus Health has 25 Employees.
- Prenexus Health grew their employee count by 0% last year.
Prenexus Health's People
Name | Title | Email/Phone |
---|
Prenexus Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.3M | 28 | -10% | N/A | N/A |
#2 | $10.2M | 47 | 4% | N/A | N/A |
#3 | $16.5M | 68 | -1% | N/A | N/A |
#4 | $5.5M | 29 | -3% | N/A | N/A |
#5 | $9.9M | 46 | 2% | N/A | N/A |
#6 | $6.7M | 31 | 0% | N/A | N/A |
#7 | $4.5M | 24 | 0% | N/A | N/A |
#8 | $15.3M | 63 | 7% | N/A | N/A |
#9 | $815.8M | 2113 | 20% | $7.5M | N/A |
#10 | $156.3M | 463 | 7% | N/A | N/A |
What Is Prenexus Health?
Prenexus Health is the exclusive manufacturer of the world's first high-fiber, sugarcane XOS prebiotic. Our fully integrated, organic supply chain ensures we are delivering the highest quality prebiotic ingredients available for food, beverage and dietary supplements. Our mission is to improve the health and wellness of individuals through the manufacturing of a high-quality, high-purity natural prebiotic ingredient grown and processed in the U.S., following sustainable environmental practices.
keywords:N/AN/A
Total Funding
25
Number of Employees
$4.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Prenexus Health News
A trend report from prebiotics supplier Prenexus Health predicts that medicinal mushrooms can make a splash in digestive health products.
... bioactive foods supporting human health (brain, immune system, ... and Prenexus Health (developing and producing prebiotic ingredients),...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.6M | 26 | -7% | N/A |
#2 | $1.9M | 27 | -21% | N/A |
#3 | $5.1M | 27 | 4% | N/A |
#4 | $5.3M | 28 | -10% | N/A |
#5 | $5.3M | 28 | 0% | N/A |